Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2019.11.13
五矿证券有限公司关于公司2019年面向及格投资者果真刊行公司债券(第一期)2019年第一次...
2019.11.13
华融证券股份有限公司关于公司2019年度累计新增乞贷凌驾上年尾净资产的百分之四十的受...
2019.11.07
关于“16Z6尊龙”公司债券回售效果的通告
2019.11.06
昔时累计新增乞贷凌驾上年尾净资产的百分之四十的通告
2019.11.04
“16Z6尊龙”2019年付息通告
2019.10.31
2019年面向及格投资者果真刊行公司债券(第一期)在深圳证券生意所上市的通告
2019.10.30
关于使用自有资金购置低危害理工业品的通告
2019.10.30
第四届董事会第二十五次聚会决议通告
2019.10.30
关于会计政策变换的通告
2019.10.30
第四届监事会第二十次聚会决议通告
第一页
上一页
41
42
43
44
45
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】